Clinical Trial Update: An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

View source ↗

Summary

A completed observational study evaluated how well BRAF inhibitors work in patients with newly diagnosed metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BRAF inhibitors (BRAF inhibitor)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Status: COMPLETED